NIMA-related kinases in cell cycle control and human disease. (360G-Wellcome-082828_Z_07_Z)

£992,664

NIMA, a serine/threonine kinase, was identified in a genetic screen as an essential regulator of mitotic entry in Aspergillus nidulans. Like other important cell cycle regulators, NIMA-related kinases are conserved across all eukaryotes. The human genome encodes eleven NIMA-related kinases (Nek1-Nek11) that form a distinct family representing about 2% of the entire kinome. We have established an international track record in studying the regulation and function of Nek2, the most closely related sequence to NIMA, demonstrating that it is a cell cycle-dependent kinase that localizes to the centrosome, regulates spindle formation upon mitotic entry and is overexpressed in human cancer. Much less is known about the other human Neks although evidence is emerging from our group and others that Nek6, Nek7 and Nek9 also regulate mitosis. Surprisingly, Nek1 and Nek8 are mutated in mouse models of polycystic kidney disease (PKD), a disease that frequently results from ciliary defects. Hence, an underlying theme for Nek kinase function may be in coordinating cell proliferation and ciliogenesis through microtubule regulation. The aim of this programme of research is to test this hypothesis by undertaking a comprehensive analysis of the regulation and function of human Neks in dividing and differentiated cells.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 992664
Applicant Surname Fry
Approval Committee Molecules, Genes and Cells Funding Committee
Award Date 2007-07-10T00:00:00+00:00
Financial Year 2006/07
Grant Programme: Title Programme Grant
Internal ID 082828/Z/07/Z
Lead Applicant Prof Andrew Fry
Other Applicant(s) Dr Mark Pfuhl, Prof Christopher O'Callaghan
Partnership Value 992664
Planned Dates: End Date 2013-09-30T00:00:00+00:00
Planned Dates: Start Date 2007-10-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region East Midlands